Modern Support for Change

Person presenting FDA letter blocks

Brand-Name GLP-1 Education

FDA-Approved Options, Explained Clearly

Learn how brand-name medications such as Wegovy and Zepbound differ from diabetes-labeled products and compounded preparations.

Understanding the Names

Why Indications Differ

The same active ingredient does not always mean the same approved use.

Semaglutide Medications

Wegovy contains semaglutide and is FDA-approved for chronic weight management in eligible patients. Ozempic also contains semaglutide but is approved for type 2 diabetes and specific related risk-reduction uses.

Tirzepatide Medications

Zepbound contains tirzepatide and is approved for chronic weight management in eligible patients. Mounjaro also contains tirzepatide but is approved for type 2 diabetes.

Finding the Right Option

The appropriate medication depends on diagnosis, medical history, insurance criteria, availability, contraindications, and shared decision-making with your physician.

Medication Comparison

Prescription Medication Overview

Brand Active Ingredient Primary Role Discussed Here
Wegovy Semaglutide FDA-approved chronic weight management
Ozempic Semaglutide FDA-approved for type 2 diabetes and labeled risk-reduction uses
Zepbound Tirzepatide FDA-approved chronic weight management
Mounjaro Tirzepatide FDA-approved for type 2 diabetes

Hope Physician Management

$99 Per Month

Medication cost is separate and depends on insurance, pharmacy, and manufacturer pricing.

Included

Monthly physician check-in, prescription management, dose review, side-effect assessment, and ongoing guidance.

Before Starting

Medical history, medications, candidacy, prior labs or baseline testing, and a discussion of realistic expectations.

During Treatment

Body composition, nutrition, hydration, muscle preservation, and long-term planning.